Arrowhead Pharmaceuticals's total assets for Q1 2025 were $1.01B, a decrease of -11.06% from the previous quarter. ARWR total liabilities were $957.62M for the fiscal quarter, a 0.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.